GeneDx Hldgs (NASDAQ:WGS) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.16 by 68.75 percent. This is a 181.82 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $87.11 million which beat the analyst consensus estimate of $85.13 million by 2.34 percent. This is a 39.56 percent increase over sales of $62.42 million the same period last year.